Kodiak Sciences Inc is a biotechnology business based in the US. Kodiak Sciences shares (KOD) are listed on the NASDAQ and all prices are listed in US Dollars. Kodiak Sciences employs 77 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Kodiak Sciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KOD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kodiak Sciences stock price (NASDAQ: KOD)Use our graph to track the performance of KOD stocks over time.
Kodiak Sciences shares at a glance
|Latest market close||$83.62|
|52-week range||$45.02 - $171.21|
|50-day moving average||$88.45|
|200-day moving average||$110.98|
|Wall St. target price||$121.60|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.50|
Buy Kodiak Sciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kodiak Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kodiak Sciences price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||-13.18%|
|3 months (2021-05-03)||-28.38%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Kodiak Sciences financials
|Gross profit TTM||$0|
|Return on assets TTM||-13.62%|
|Return on equity TTM||-27.69%|
|Market capitalisation||$4.3 billion|
TTM: trailing 12 months
Shorting Kodiak Sciences shares
There are currently 3.6 million Kodiak Sciences shares held short by investors – that's known as Kodiak Sciences's "short interest". This figure is 2.4% up from 3.5 million last month.
There are a few different ways that this level of interest in shorting Kodiak Sciences shares can be evaluated.
Kodiak Sciences's "short interest ratio" (SIR)
Kodiak Sciences's "short interest ratio" (SIR) is the quantity of Kodiak Sciences shares currently shorted divided by the average quantity of Kodiak Sciences shares traded daily (recently around 290389.92747784). Kodiak Sciences's SIR currently stands at 12.41. In other words for every 100,000 Kodiak Sciences shares traded daily on the market, roughly 12410 shares are currently held short.
However Kodiak Sciences's short interest can also be evaluated against the total number of Kodiak Sciences shares, or, against the total number of tradable Kodiak Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kodiak Sciences's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Kodiak Sciences shares in existence, roughly 70 shares are currently held short) or 0.1156% of the tradable shares (for every 100,000 tradable Kodiak Sciences shares, roughly 116 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Kodiak Sciences.
Find out more about how you can short Kodiak Sciences stock.
Kodiak Sciences share dividends
We're not expecting Kodiak Sciences to pay a dividend over the next 12 months.
Kodiak Sciences share price volatility
Over the last 12 months, Kodiak Sciences's shares have ranged in value from as little as $45.02 up to $171.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kodiak Sciences's is 1.3829. This would suggest that Kodiak Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Kodiak Sciences overview
Kodiak Sciences Inc. , a clinical stage biopharmaceutical company, engages in researching, developing, and commercializing therapeutics to treat retinal diseases in the United States and international markets. Its lead product candidate is KSI-301, a vascular endothelial growth factor (VEGF)-biological agent that is in Phase 1b clinical study to treat wet age-related macular degeneration (AMD) and diabetic retinopathy, including diabetic macular edema, as well as for macular edema due to retinal vein occlusion. The company's preclinical stage product candidate includes KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate conjugate to treat neovascular retinal diseases with an inflammatory component. Its early research pipeline includes KSI-601, a triplet inhibitor for the treatment of multifactorial retinal diseases, such as dry AMD and the neurodegenerative aspects of glaucoma. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015.
Stocks similar to Kodiak Sciences
Kodiak Sciences in the news
TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook
Is This Mid-Cap Biotech Stock a Buy Now?
Were Hedge Funds Right About Selling Kodiak Sciences Inc (KOD)?
Frequently asked questionsWhat percentage of Kodiak Sciences is owned by insiders or institutions?
Currently 10.958% of Kodiak Sciences shares are held by insiders and 89.523% by institutions. How many people work for Kodiak Sciences?
Latest data suggests 77 work at Kodiak Sciences. When does the fiscal year end for Kodiak Sciences?
Kodiak Sciences's fiscal year ends in December. Where is Kodiak Sciences based?
Kodiak Sciences's address is: 1200 Page Mill Road, Palo Alto, CA, United States, 94304 What is Kodiak Sciences's ISIN number?
Kodiak Sciences's international securities identification number is: US50015M1099 What is Kodiak Sciences's CUSIP number?
Kodiak Sciences's Committee on Uniform Securities Identification Procedures number is: 50015M109
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert